Cardiology
News
‘Cautious’ DOAC underdosing in AFib may push mortality higher
Risk-averse clinicians might be doing more harm than good by prescribing direct oral anticoagulants at lower-than-recommended dosages in hope of...
News
Observational study again suggests lasting impact of COVID-19 on heart
News
Many providers don’t follow hypertension guidelines
Most health care professionals rely on clinic BP measurements to make a new diagnosis of hypertension, and view pressure measured manually with a...
News
The earlier the better for colchicine post-MI: COLCOT
One substudy supported in-hospital initiation of colchicine and a second offered clues as to who may respond or experience tell-tale GI events.
News
MIS-C cardiac evaluation requires more than EF
News
Statins linked to reduced mortality in COVID-19
A pooled analysis of available data suggest moderate- to high-intensity statin therapy may be beneficial in patients with COVID-19, researchers...
News
Minidose edoxaban may safely cut AFib stroke risk in the frail, very elderly
Those who took the factor Xa inhibitor edoxaban (Savaysa) at the off-label dosage of 15 mg once daily showed a two-thirds drop in risk for stroke...
News
REALITY trial supports restrictive transfusion in anemic MI
Restrictive transfusion proves more effective and less costly than liberal transfusion.
News
First randomized trial reassures on ACEIs, ARBs in COVID-19
The BRACE CORONA study found no difference in key outcomes between patients continuing versus stopping their medication.
News
HOME-PE trial clarifies which pulmonary embolism patients to treat at home
“Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides